Related references
Note: Only part of the references are listed.Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Improving performance of liver biopsy in fibrosis assessment
Tarik Asselah et al.
JOURNAL OF HEPATOLOGY (2014)
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
Vincenza Calvaruso et al.
LIVER INTERNATIONAL (2014)
Long-term therapy for chronic hepatitis B: Hepatitis B virus DNA suppression leading to cirrhosis reversal
Patrick Marcellin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis
Seung Up Kim et al.
JOURNAL OF HEPATOLOGY (2012)
Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
Eugene R. Schiff et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
Seung Up Kim et al.
HEPATOLOGY INTERNATIONAL (2010)
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension
Spilios Manolakopoulos et al.
JOURNAL OF HEPATOLOGY (2009)
Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C
Vincent Mallet et al.
ANNALS OF INTERNAL MEDICINE (2008)
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C
Sarah Maylin et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
Shi-Ming Lin et al.
JOURNAL OF HEPATOLOGY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking
R Issa et al.
GASTROENTEROLOGY (2004)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
V Paradis et al.
HUMAN PATHOLOGY (2001)
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
KL Rudolph et al.
SCIENCE (2000)
Share Paper
